Supraspinal antinociceptive effects of μ and δ agonists involve modulation of adenosine uptake

Anesthesiology

Volumn 98, Issue 2, 2003, Pages 459-464

  Pham, Thao ^a,b   Carrega, Louis ^a   Sauze, Nicole ^a   Fund Saunier, Odile ^a   Devaux, Christiane ^a   Peragut, Jean Claude ^b   Saadjian, Alain ^c   Guieu, Régis ^a,b  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; DELTA OPIATE RECEPTOR AGONIST; ISOFLURANE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OXYMORPHONE; DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HOT PLATE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL; ANIMAL; BRAIN LEVEL; C57BL MOUSE; DRUG EFFECT; DRUG POTENTIATION; EXTRACELLULAR SPACE; INJECTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PAIN ASSESSMENT; REACTION TIME; SPINAL CORD; SYNAPTOSOME;

ADENOSINE; ANALGESICS, OPIOID; ANIMALS; BRAIN CHEMISTRY; CAFFEINE; EXTRACELLULAR SPACE; FEMALE; INJECTIONS; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED C57BL; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SPINAL CORD; SYNAPTOSOMES;

EID: 0037312990     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200302000-00027     Document Type: Article

References (26)

1. Sawynok J: Adenosine receptor activation and nociception. Eur J Pharmacol 1998; 317:1-11
2. Sweeney MI, White TD, Sawynok J: Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J Pharmacol Exp Ther 1987; 243:657-65
3. Sweeney MI, White TD, Jhamandas KH, Sawynok J: Morphine releases endogenous adenosine from the spinal cord in vivo. Eur J Pharmacol 1987; 141:169-70
4. Plagemann PG, Wohlhueter RM, Woffendin C: Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 1988; 947:405-43
5. Sweeney MI, White TD, Sawynok J: Morphine-evoked release of adenosine from the spinal chord via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res 1993; 614:301-7
6. Kaplan GB, Leite-Morris KA: Up-regulation of adenosine transporter-binding in striatum and hypothalamus of opiate-tolerant mice. Brain Res 1997; 763: 215-20
7. DeLander GE, Mosberg HI, Porreca F: Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonist: Dissociation from gastrointestinal effects in mice. J Pharmacol Exp Ther 1992; 263:1097-104
8. DeLander GE, Keil GJ: Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists. J Pharmacol Exp Ther 1994; 268:943-51
9. Lavand'homme PM, Eisenach JC: Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 1999; 80:31-6
10. Cahill CM, White TD, Sawynok J: Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. J Pharmacol Exp Ther 1995; 275:84-93
11. Keil GJ, Delander GE: Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 1995; 274:1387-92
12. Ochi T, Fujii T, Motoyama Y, Goto T: Antinociceptive properties of FR140423 mediated through spinal δ, but not μ and κ, opioid receptors. Eur J Pharmacol 1999; 380:73-9
13. Halimi G, Devaux C, Clot-Faybesse O, Sampol J Jr, Legof L, Rochat H, Guieu R: Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur J Pharmacol 2000; 398:217-24
14. Guieu R, Sampieri F, Bechis G, Halimi G, Dussol B, Berland Y, Sampol J, Rochat H: Development of an HPLC/diode array detector method for the determination of human plasma adenosine concentrations. J Liq Chrom 1999; 22: 1829-41
15. Guieu R, Peragut JC, Roussel P, Hassani H, Sampieri F, Bechis G, Gola R, Rochat H: Adenosine and neuropathic pain. Pain 1996; 68:271-4
16. Sawynok J, Reid AR, Doak GJ: Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: Involvement of noradrenergic mechanisms. Pain 1995; 61:203-13
17. Malec D, Michalska E: The effects of methylxanthines on morphine analgesia in mice and rats. Pol J Pharmacol Pharm 1988; 40:223-32
18. Misra AL, Pontani RB, Vadlamani NL: Potentiation of morphine analgesia by caffeine. Br J Pharmacol 1985; 84:789-91
19. Ghelardini C, Galeotti N, Bartolini A: Caffeine induces central cholinergic analgesia. Naunyn Schmiedbergs Arch Pharmacol 1997; 356:590-5
20. Daly JW: Caffeine, Coffee and Health, 3rd edition. Edited by Garattini S. New York, Raven Press, 1993, pp 97-150
21. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ: Comparative pharmacology of human adenosine receptor subtypes: Characterization of stably transfected receptors in CHO cells. Naunyn Schmiedbergs Arch Pharmacol 1998; 357:1-9
22. Cahill CM, White TD, Sawynok J: Influence of calcium on the release of endogenous adenosine from spinal cord synaptosomes. Life Sci 1993; 53:487-96
23. Cahill CM, White TD, Sawynok J: Involvement of calcium channels in depolarization-evoked release of adenosine from spinal cord synaptosomes. J Neurochem 1993; 60:886-93
24. Sawynok J, Sweeney MI, White TD: Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 1986; 88:923-30
25. DeLander GE, Hopkins CJ: Involvement of A2 adenosine receptors in spinal mechanisms of antinociception. Eur J Pharmacol 1987; 139:215-23
26. 3H] NECA in rat striation membranes. Mol Pharmacol 1986; 29:331-46